Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Marcio H. Malogolowkin MD
Chief, Professor
Department of Pediatrics
Division of Hematology/Oncology

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
1/1977 - 12/1982 MD, Federal University of Rio de Janeiro Medical School, Rio de Janeiro, Brazil

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1/1982 - 12/1982 Medical Intern, Federal University of Rio de Janeiro Medical School, Rio de Janeiro, Brazil,
7/1986 - 6/1989 Fellow, Pediatrics, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
2/1990 - 2/1991 Intern, Pediatrics, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
2/1991 - 2/1992 Resident, Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA
7/1993 - 6/1994 Resident, Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA

FACULTY APPOINTMENTS:
1977 - 1981 Instructor, Exercise Physiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil,
1980 - 1982 Instructor, Pathology, University of Augusto Motta, Rio de Janeiro, Brazil,
1989 - 1990 Clinical Instructor, Pediatrics, University of Southern California, Los Angeles, CA
1990 - 1997 Assistant Professor, Pediatrics, University of Southern California, Los Angeles, CA
1997 - 2000 Associate Professor, Pediatrics, Hematology/Oncology, University of California Los Angeles, Los Angeles, CA
8/2000 - 10/2004 Associate Professor, Pediatrics, Hematology/Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA
10/2004 - 10/2011 Associate Professor, Clinical Scholar, Pediatrics, Hematology/Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA
8/2011 - Professor, Clinical Scholar, Pediatrics, Hematology/Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA
11/2011 - Present Tenured Professor, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
11/2011 - Present Director, MACC Fund Center for Cancer and Blood Disorders, Children's Hospital of Wisconsin, Milwaukee, WI
11/2011 - Present Chief, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI
11/2011 - Present Associate Director, Cancer Center, Pediatric Oncology, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
1991 - 1992 Acting Director, Fellowship Training Program, Pediatrics, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
1997 - 2000 Director, Fellowship Training Program, Pediatrics, Hematology-Oncology, Mattel Children's Hospital, University of California Los Angeles, Los Angeles, CA

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
1991 - 1995 Coordinator of Inpatient Care, Pediatrics, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
12/1995 - 8/1997 Director, Bone and Soft Tissue Tumor Program, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
1997 - 2000 Clinical Director, Pediatrics, Hematology-Oncology, University of California Los Angeles, Los Angeles, CA
2000 - 10/2011 Director, Pediatrics, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
2000 - 12/2007 Deputy Division Head, Clinical Affairs, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
2000 - 10/2011 Director, Bone and Soft Tissue Tumor Program, Children's Hospital Los Angeles, Los Angeles, CA
1/2008 - 10/2011 Division Head, Clinical Affairs and Clinical Research, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA
1/2009 - 10/2011 Medical Director, Service Line, Children's Hospital Los Angeles, Los Angeles, CA
11/2011 - Present Director, MACC Fund Center for Cancer and Blood Disorders, Children's Hospital of Wisconsin, Milwaukee, WI
11/2011 - Present Chief, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI

RESEARCH ADMINISTRATIVE APPOINTMENTS:
1977 - 1981 Junior Researcher, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil,
1989 - 2008 Coordinator, Protocol Development, Children's Cancer Study Group (CCSG), Arcadia, CA
1991 - 1997 Children's Cancer Group (CCG) Studies Core Coordinator, Children's Hospital Los Angeles, Los Angeles, CA
1995 - 1997 Co-Principal Investigator, Children's Cancer Study Group (CCSG),
1995 - Acting Principal Investigator, Children's Cancer Study Group (CCSG),
2004 - 2011 Director, Clinical Research, Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA

HOSPITAL STAFF PRIVILEGES:
12/2000 - 11/2011 Attending Physician, Pediatrics, Hematology-Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
9/2003 - 10/2011 Consulting Physician, Pediatrics, Hematology-Oncology, Huntington Memorial Hospital, Pasadena, CA
1/2005 - 11/2011 Consulting Physician, Pediatrics, Hematology-Oncology, Miller Children's Hospital, Long Beach, CA
1/2010 - 9/2011 Consulting Physician, Pediatrics, Hematology-Oncology, Providence St. Joseph Medical Center, Burbank, CA
2011 - Present Attending Physician, Pediatrics, Hematology/Oncology/BMT, Children's Hospital of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Pediatrics
1998
None
American Board of Pediatrics Hematology-Oncology
1998
None
 
Licensure
Number Issue DateExpiration
National Institute of Health, Brazil
1982
None
ECFMG
1983
None
VQE
1985
None
FLEX
1990
None
California State Board
1991
None
Wisconsin Medical License
2012
None
 
AWARDS AND HONORS:
2005 Morris & Mary Press Humanism Award, Children's Hospital Los Angeles
2008 - 2011 Best Doctors in America
2010 - 2011 Top Doctors, Pasadena Magazine
2010 - 2012 Super Doctors, Los Angeles Magazine
2011 - 2012 Best Doctors in America®, Milwaukee-Racine-Kenosha Metro Area

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
American Society of Clinical Oncology (Member)
Brazilian Society of Pediatric Hematology-Oncology (Member)
American Society of Pediatric Hematology-Oncology (Member)
Sociedad Latino-Americana de Oncologia-Pediatrica (SLAOP) (Member)
Brazilian Society of Clinical Pathology (Past Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
2009 Pediatric Liver Tumors - Springer-Verlag; Zimmermann A, Perilongo G, Malogolowkin M, von Schweinitz D (Eds.)
Journal Review
Journal of Clinical Oncology
New England Journal of Medicine
Journal of Pediatric Hematology-Oncology
Pediatric Blood & Cancer

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1995 - 2001 Member, Clinical Research Assistants Committee, Children's Cancer Study Group (CCSG)
1995 - 2001 Member, Wilms Tumor Strategy Group, Children's Cancer Study Group (CCSG)
1995 - 2001 Member, National Wilms’ Tumor Study Committee
1995 - 2001 Member, Specimen Submission Guidelines Committee, Children's Cancer Study Group (CCSG)
1995 - 2001 Member, Soft Strategy Group, Children's Cancer Study Group (CCSG)
2001 - Present Member, PDQ® Pediatric Cancer Treatment Advisory Board, National Cancer Institute (NCI)
2001 - Present Member, Rare Tumors Committee, Children's Oncology Group (COG)
2001 - Present Member, Germ Cell Tumor Subcommittee, Children's Oncology Group (COG)
2001 - Present Member, Renal Tumors Committee, Children's Oncology Group (COG)
2001 - 2009 Chairman, Liver Tumor Subcommittee, Children's Oncology Group (COG)
2007 - Present Member, Medical Advisory Board, Christopher’s Living Hope Foundation
2007 - Present Leader, Liver Tumor Committee, LiveStrong - NCI Young Adult Alliance Science Task Force
2008 - Present International Health Advisor, John Dau Sudan Foundation
2009 - Present Vice Chair, Liver Tumor Subcommittee, Children's Oncology Group (COG)

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
P9346 – Hepatoblastoma Biology Study and Tissue Bank
Role:
Member
Dates:
1996 - Present
 
Title:
Multi-Drug Resistance Gene Expression In Wilms Tumors: Correlation With Outcome
Role:
Chair
Dates:
2005 - 2010
 
Title:
AGCT052: Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin Treatment of Children with Recurrent Germ Cell Tumors
Role:
Member
Dates:
2007 - Present
 
Title:
AHEPO731: Treatment of Children with All Stages of Hepatoblastoma
Role:
Vice Chair
Dates:
2007 - Present
 
Title:
Phase I trial of Oxaliplatin and Doxorubicin in children and Adolescents with relapsed and refractory extra-cranial solid tumors of non-hematopoietic origin (CCI# 06-00092) - Study Opened
Role:
Co-Investigator
Dates:
2009 - Present
 
Title:
A Phase I Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin (VIT-B)
Source:
Children's Hospital Los Angeles
Role:
Co-Investigator
PI:
Rajkumar Venkatramani, MD, Children's Hospital Los Angeles
Dates:
2010 - Present
 
Title:
ADVL1121 – A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (IND# 69896) in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma. Study Opened.
Role:
Member
Dates:
2011 - Present
 
Title:
Diffusion-Weighted Imaging to Evaluate Cellularity of Solid Tumors in Children, Adolescents and Young Adults
Source:
Cancer Imaging Research Program Seed Grant - MCW Cancer Center
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
4/1/2013 - 3/30/2014
Direct Funds:
$10,000
 
Prior
Peer Review
Title:
Predictability of Platinum Levels (AUC) Using Calvert’s Formula
Source:
Bristol-Myers Squibb U.S. Pharmaceutical Group
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
1992
Direct Funds:
$12,000 (2% effort)
 
Title:
Pilot Study for the Treatment of Isolated CNS Relapse in Children with Lymphoblastic Leukemia
Source:
Parker Hughes Trust
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
1995 - 1997
Direct Funds:
$10,000 (2.5% effort)
 
Title:
Pilot Study for the Treatment of Isolated CNS Relapse in Children with Lymphoblastic Leukemia
Source:
Rhone-Poulenc Rorer Pharmaceutical Inc.
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
1995
Direct Funds:
$10,000 (2.5% effort)
 
Title:
The Efficacy of Granisetron in Controlling Chemotherapy Induced Emesis in the Pediatric Population
Source:
SmithKline-Beechem
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
1995 - 1997
Direct Funds:
$7,000 (5% effort)
 
Title:
CCG 8961 – Chemoembolization for the Treatment of Children with Unresected Non-metastatic Hepatocellular Carcinoma or Chemotherapy Resistant Unresected Non-Metastatic Primary Liver Tumors
Role:
Co-Chair
Dates:
1997 - 1999
 
Title:
Pediatric Cancer Research Foundation Consortium
Source:
UCLA Mattel Children’s Hospital
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
1998 - 2000
 
Title:
P9645 - Intergroup Hepatoblastoma Study
Role:
Co-Chair
Dates:
1999 - 2006
 
Title:
CCG 6921 – Treatment of Advanced Rhabdomyosarcoma and Other Soft Tissue Sarcomas
Role:
Chair
Dates:
1999 - 2001
 
Title:
P9749 – Pilot Intergroup Study of High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined with Amifostine in Children with High-Risk Malignant Germ Cell Tumor
Role:
Co-Chair
Dates:
2000 - 2002
 
Title:
Liver Tumor Subcommittee
Source:
NIH/NCCF/Children’s Oncology Group
Role:
Chair
Dates:
3/1/2003 - 2/29/2004
Direct Funds:
$12,500 (10% effort)
 
Title:
ADVL0421- Phase II Study of Oxaliplatin in Children with Recurrent Solid Tumor
Role:
Co-Chair
Dates:
2004 - 2006
 
Title:
AGCT-01P1: Pilot Intergroup Study of Cyclophosphamide, Cisplatin, Etoposide in Children with High-Risk Malignant Germ Cell Tumor
Role:
Chair
Dates:
2004 - 2007
 
Title:
Low Birth Weight and Other Risk Factors in Hepatoblastoma
Source:
University of Minnesota, Subcontract
Role:
Co-Investigator
Dates:
2/18/2005 - 1/31/2010
Direct Funds:
$16,900 (5% effort)
 
Title:
Liver Tumors
Source:
National Childhood Cancer Foundation/Children’s Oncology Group
Role:
Chair
Dates:
3/1/2005 - 8/31/2008
Direct Funds:
$16,900 (5% effort)
 
Title:
AEPI04C1: Low Birth Weight and Other Risk Factors for Hepatoblastoma
Role:
Member
Dates:
2005 - 2010
 
Title:
Correlative Genetic Markers in Hepatoblastoma
Source:
University of Texas South Western Medical Center, Subcontract
Role:
Co-Investigator
Dates:
9/30/2009 - 9/29/2010
Direct Funds:
$16,900 (5% effort)
 
Non-Peer Review
Title:
A Study of Chemoembolization with Angiostat Collagen, Cisplatin, and Doxorubicin in Children with Recurrent Liver Tumors
Source:
The Cancer Research Foundation of America
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
1991 - 1994
Direct Funds:
$0 (Unfunded)
 
Title:
Knowledge Empowerment for Youth with Solid Tumor
Source:
The Degge Group, Ltd./SBIR Solid Tumor Grant – Phase II (Funding Source)
Role:
Principal Investigator
PI:
Marcio Malogolowkin, MD
Dates:
2/21/2003 - 1/31/2005
Direct Funds:
$0 (5% effort. No funding.)
 
INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
1. Neuroblastoma: Diagnosis and Treatment, Department of Radiation Oncology Presentation with Dr. H. Shimada, USC Medical School, 1989
2. Drug Resistance in Pediatrics, Grand Rounds, Division of Hematology-Oncology, University of California at Los Angeles, Los Angeles, CA, 1994
3. Principles of Bone Marrow Transplantation, Presentation to Kaiser Permanente Pediatric House Staff, 1995
4. Differential Diagnosis of Abdominal Masses, Presentation to Pediatric House Staff, Kaiser Permanente, 1995
5. Successful CSF Asparaginase (ASN) Depletion Following Administration of PEG-Asparaginase (PEG-ASNase) in Children with Acute Lymphoblastic Leukemia (ALL) with Isolated CNS Relapse, International Symposium on Asparaginase and Its Implications in the Treatment of Leukemia and Lymphoma, Children's Hospital Los Angeles, 1998
6. Principles of Chemotherapy, Chemotherapy Class, UCLA Children’s Hospital, Nursing Staff, Los Angeles, CA, 1998
7. Pediatric Oncology Case Presentation, Los Angeles Community Hospital, Los Angeles, CA, 1998
8. Abdominal Masses in Children: Evaluation and Differential Diagnosis, Pediatric Grand Rounds, UCLA Children’s Hospital, Los Angeles, CA, 1999
9. Doctoring in Today’s Health Care Market, CHLA Student Executive Forum for UCLA Graduate Students, Children's Hospital Los Angeles, Los Angeles, CA, 2001
10. Childhood Cancer, Huntington Memorial Hospital, 2003
11. Liver Tumors in Children, Adolescents, and Young Adults: Treatment, Prognosis, Outcome and Future Goals, Cancer Conference, Children's Hospital Orange County, Orange, CA, 11/2004
12. Advances in Treatment of Children with Solid Tumors, Millers Children’s Hospital, Long Beach, CA, 6/2006
13. The Adolescent and Young Adult Program, Providence Saint Joseph, Burbank, CA, 7/2010
14. Suspicion of and Management of Soft Tissue Sarcomas, Providence St. Joseph Medical Center, Burbank, CA, 4/2011
15. Pediatric Liver Tumors: A model for clinical research and international cooperation, Children's Hospital Los Angeles, Los Angeles, CA, 9/2011
16. Pediatric Liver Tumors: A model for clinical Research and International cooperation, Kaiser Permanente, Los Angeles, CA, 10/2011
17. Current Status, Outcomes & Challenges in Pediatric Oncology, Challenges to Care - Center for Bioethics & Medical Humanities Institute for Health & Society, Medical College of Wisconsin, Milwaukee, WI, 12/2013
18. Pediatric Liver Tumors: A Model for Clinical Research and International Cooperation, Pediatric Grand Rounds, Children's Hospital of Wisconsin, 5/2014
 
Regional
1. Differential Diagnosis of Abdominal Tumors in Children, 11th Annual Meeting Association of Pediatric Oncology Nurses, Southern California Chapter, 1997
2. Surfing Through the Differential Diagnosis of Bone Tumors, SCAPON 15th Annual Regional Conference on Pediatric Oncology Nursing, 2001
3. Treatment of Pediatric Germ Cell Tumors, SCAPHON. The Twenty-Third Regional Conference on Pediatric Hematology & Oncology Nursing, Dana Point, CA, 5/2009
4. Pediatric Liver Tumors: A model for clinical research and international cooperation, UW-Madison, Department of Pediatrics, Madison, WI, 5/2012
 
National
1. Toxicity and Side Effects, Children's Cancer Study Group Data Managers Seminar, St. Louis, MO, 1991
2. Brain Tumors, Children's Cancer Study Group Data Managers Seminar, St. Louis, MO, 1991
3. Review of Leukemia and Solid Tumors, Children's Cancer Study Group Data Managers Seminar, 1992
4. Overview of Pediatric Oncology, Children's Cancer Study Group Data Managers Seminar, 1992
5. Chemotherapy and Clinical Trials, Children's Cancer Study Group Data Managers Seminar, 1992
6. The Trend to Outpatient Cancer Treatment and the Evolving Role of the Primary Care Physician, Interactive Scientific Meeting, sponsored by Glaxo, Inc., 1992
7. Overview of Study Design, Study Chairman Workshop, Children's Cancer Group, Dallas, TX, 1994
8. Protocol Design, Study Chairman Workshop, Children's Cancer Group, Chicago, IL, 1995
9. Overview of Study Design, Study Chairman Workshop, Children's Cancer Group, Houston, TX, 1995
10. Chemoembolization of Liver Tumors, Local Tumor Control Conference, Children's Cancer Group, Houston, TX, 1995
11. Overview of Study Design, Study Chairman Workshop, Children's Cancer Group, Cleveland, OH, 1997
12. Overview of Study Design, Study Chairman Workshop, Children's Cancer Group, Houston, TX, 1998
13. Overview of Study Design, Study Chairman Workshop, Children's Cancer Group, Cleveland, OH, 1998
14. Current Status of Hepatoblastoma, Children's Oncology Group Meeting, COG Surgery Education Session, Jacksonville, FL, 2002
15. NWTS-5: Therapeutic Trial and Biology Study (COG 4941), Children's Oncology Group Site Visit Rehearsal, Houston, TX, 2002
16. Update on Liver Tumor Biology and Therapeutic Studies, Fall Children's Oncology Group Meeting, St. Louis, MO, 2002
17. Rare Tumors (including liver and germ), Fall Children's Oncology Group Meeting, Chicago, IL, 2004
18. Rare Tumors (including liver and germ), Spring Children's Oncology Group Meeting, Washington, DC, 2004
19. Radiology/Pathology Educational Session: Clinical Aspects of Pediatric Hepatic Tumors, Fall Children's Oncology Group Meeting, Dallas, TX, 2005
20. CRA Continuing Education: Pediatric Germ Cell Tumors, Fall Children's Oncology Group Meeting, Dallas, TX, 2005
21. Clinical Trials-North American Experience, American Society of Pediatric Hematology Oncology, Baltimore, MD, 4/2011
22. Focus on Hepatoblastoma High Risk Tumors, American Pediatric Surgical Association (APSA) - International Society of Paediatric Surgical Oncology (IPSO) 43rd Annual Meeting Symposium, San Antonio, TX, 5/19/2012
23. Pediatric Liver Tumors: A model for clinical research and international cooperation, The Children's Mercy Hospital, Kansas City, MO, 10/2012
24. Research: So You Want to Do Clinical Research?, Society for Pediatric Dermatology, 39th Annual Meeting, Pfister Hotel, Milwaukee, WI, 7/13/2013
25. Pediatric Liver Tumors: A Model of Clinical Reasearch ans International Cooperation, Grand Rounds Presentation to Hyundai Cancer Institute Staff, Children's Hospital Orange County, Orange, CA, 1/31/2014
 
International
1. Rhabdomyosarcomas, Oncology Grand Rounds, Instituto Nacional de Cancer, Rio de Janeiro, Brazil, 1988
2. Central Nervous System Infections in Children with Cancer, Symposium in Pediatric Central Nervous System Infections, Hospital da Lagoa, Rio de Janeiro, Brazil, 1989
3. Pediatric Germ Cell Tumors, Oncology Grand Rounds, Instituto Nacional de Cancer, Rio de Janeiro, Brazil, 1989
4. Childhood Cancer: An Overview, Pediatric Grand Rounds, Hospital Sao Vicente da Gavea, Rio de Janeiro, Brazil, 1989
5. Protocol Development for Pediatric Oncology, Instituto Nacional de Cancer, Rio de Janeiro, Brazil, 1989
6. Medical Informatics and Protocol Development, Instituto da Crianca, Universidade de Sao Paulo, Sao Paulo, Brazil, 1989
7. Treatment of Advanced Stage Rhabdomyosarcomas, Hematology-Oncology Grand Rounds, B.C. Children’s Hospital, University of British Columbia, Vancouver, Canada, 1990
8. Chemoembolization for Pediatric Liver Tumors, CELTIC (International Liver Tumor Group), Hanover, Germany, 1992
9. Drug Resistance in Cancer, A.C. Camargo Hospital, Sao Paulo, Brazil, 1992
10. Bone Marrow Transplant for Advanced Rhabdomyosarcoma, A.C. Camargo Hospital, Sao Paulo, Brazil, 1992
11. Germ Cell Tumors – Overview and CHLA Experience, Meeting Grupo Cooperativo Brasileiro para o Tratamento dos Tumores de Celulas Germinativas, A.C. Camargo Hospital, Sao Paulo, Brazil, 1993
12. Drug Resistance, Wilms Tumor, South American Meeting, Sao Paulo, Brazil, 1993
13. Liver Tumors: New Methods of Treatment, National Cancer Institute of Rio de Janeiro, Rio de Janeiro, Brazil, 1993
14. Liver Tumors: New Methods of Treatment, A.C. Camargo Hospital, Sao Paulo, Brazil, 1993
15. Overview of Cancer: Chemotherapy and Clinical Trials, Pediatric Grant Rounds, Hospital da Lagoa, Rio de Janeiro, Brazil, 1993
16. Rhabdomyosarcoma, A.C. Camargo Hospital, Sao Paulo, Brazil, 1993
17. Wilms Tumor: The Children's Hospital Los Angeles Experience, South American Meeting, Sao Paulo, Brazil, 1993
18. Peripheral Blood Stem Cell Transplant, Centro Infantil de Investigacoes Hematologicas, Campinas, Brazil, 1994
19. Drug Resistance in Pediatric Cancer, Centro Infantil de Investigacoes Hematologicas, Campinas, Brazil, 1994
20. Germ Cell Tumors, National Cancer Institute of Rio de Janeiro, Rio de Janeiro, Brazil, 1995
21. Treatment of Pediatric Liver Tumors, 4th Reunion Binacional de Actualizacion en Pediatria, La pediatria en Albores del siglo XXI, Centro Universitario Contra El Cancer, Monterrey, Mexico, 1995
22. Liver Tumors, II Reunion Nacional de Agrupacion Mexicana de ONCO-Hematologia Pediatrica, Villahermosa, Tabasco, Mexico, 1995
23. The Future in the Treatment of Brain Tumors in Childhood, 4th Reunion Binacional de Actualizacion en Pediatria, La pediatria en Albores del Siglo XXI, Centro Universitarior Contra El Cancer, Monterrey, Mexico, 1995
24. Wilms Tumor, II Reunion Nacional de Agrupacion Mexicana de ONCO-Hematologia Pediatrica, Villahermosa, Tabasco, Mexico, 1995
25. Wilms Tumor, National Cancer Institute of Rio de Janeiro, Rio de Janeiro, Brazil, 1995
26. Overview of Study Design, Study Chairman Workshop, Children's Cancer Group, Vancouver, Canada, 1996
27. CNS Leukemia, Centro Infantil de Investigacoes Hematologicas, Campinas, Brazil, 1997
28. Oncologic Emergencies, Centro Infantil de Investigacoes Hematologicas, Campinas, Brazil, 1997
29. Germ Cell Tumors, Primera Reunion Internacional de Oncologia del Noreste, Monterey, N.L., Mexico, 1998
30. Wilms Tumor, Primera Reunion Internacional de Oncologia del Noreste, Monterey, N.L., Mexico, 1998
31. Clinical Research in Pediatric Hematology-Oncology, Institute of Pediatric Oncology (IOP), Sao Paulo, Brazil, at the Universidad Federal de Sao Paulo Escola Paulista de Medicine, Department of Pediatrics (UNIFESP/EPM), Sao Paulo, Brazil, 2000
32. Long Term Effects in Pediatric Cancer Treatment, Institute of Pediatric Oncology (IOP), Sao Paulo, Brazil, at the Universidad Federal de Sao Paulo Escola Paulista de Medicine, Department of Pediatrics (UNIFESP/EPM), Sao Paulo, Brazil, 2000
33. Hepatic Tumors in Pediatrics, Primeras Jornadas LatinoAmericano-Israelies De Hemato-Oncologia Pediatrica, Montevideo-Uruguay, 2001
34. BMT for Solid Tumors, Primeras Jornadas LatinoAmericano-Israelies De Hemato-Oncologia Pediatrica, Montevideo-Uruguay, 2001
35. The American INTERGROUP Studies, ECCO 11 Conference, Lisbon, Portugal, 2001
36. Histology and Other Treatment Related Prognostic Factors, ECCO 11 Conference, Lisbon, Portugal, 2001
37. SIOPEL Committee, International Research Consortium on Childhood Liver Tumours – Phase II Study, Padova, Italy, 2002
38. SIOPEL Committee, International Research Consortium on Childhood Liver Tumours – Mini-symposium on childhood hepatocellular carcinoma, Padova, Italy, 2002
39. Results of Treatment with Chemotherapy in Non-Resectable Hepatoblastoma and Update of Wilms Tumor, Pan-American Pediatric Surgical Congress Meeting, Acapulco, Mexico, 2002
40. Workshop I: International Relapsed Wilms Tumour Study, UKCCSG Biology of Childhood Cancer Meeting, The Mitchell Ross Symposium on High Risk Embryonal Tumours, London, England, 2002
41. New Drugs and New Strategies for the Treatment of Extraocular Retinoblastoma, I International Symposium of Retinoblastoma, Sao Paulo, Brazil, 2003
42. Liver Tumors in Children, Adolescents, and Young Adults, I International Symposium of Retinoblastoma, Sao Paulo, Brazil, 2003
43. A Randomized Study of Chemotherapy With or Without Antiangiogenic Agents for the Treatment of Patients with Hepatocellular Carcinoma, ACOSOG, Montreal, Canada, 2003
44. Chemotherapy for Intraocular Retinoblastoma, I International Symposium of Retinoblastoma, Sao Paulo, Brazil, 2003
45. Second Malignant Neoplasms After Retinoblastoma Treatment of Extraocular Retinoblastoma, I International Symposium of Retinoblastoma, Sao Paulo, Brazil, 2003
46. Metastatic Osteosarcoma Treatment Results, 8th International Pediatric Oncology Meeting, Mexico City, Mexico, 2003
47. Langerhan’s Histiocytosis, I International Symposium of Retinoblastoma, Sao Paulo, Brazil, 2003
48. Strategies of Treatment in Renal Sarcomas, 8th International Pediatric Oncology Meeting, Mexico City, Mexico, 2003
49. Liver Tumors in Children, Adolescents and Young Adults, Annual Russian Academy of Medical Sciences, Moscow, Russia, 11/2004
50. Soft Tissue Sarcomas in Children and Adolescents: Treatment, Prognosis, Outcome and Future Goals, Annual Russian Oncology Meeting, Moscow, Russia, 11/2004
51. Germ Cell Tumors in Children, Annual Russian Academy of Medical Sciences, Moscow, Russia, 11/2004
52. Neuroblastoma: Indications and Outcomes of Bone Marrow Transplant, XX Congress Latin American Society of Pediatric Oncology (SLAOP) Meeting, Campo Grande, Brazil, 4/2005
53. Soft Tissue Sarcomas, XX Congress Latin American Society of Pediatric Oncology (SLAOP) Meeting, Campo Grande, Brazil, 4/2005
54. Prognostic Factors of Non-Rhabdomyosarcomas, Soft Tissue Sarcomas, XX Congress Latin American Society of Pediatric Oncology (SLAOP) Meeting, Campo Grande, Brazil, 4/2005
55. Hepatoblstoma, XX Congress Latin American Society of Pediatric Oncology (SLAOP) Meeting, Campo Grande, Brazil, 4/2005
56. Treatment of Recurrent Wilm’s Tumor, International Treatment Protocol Proposal, XXX Congress Latin American Society of Pediatric Oncology (SLAOP) Meeting, Campo Grande, Brazil, 4/2005
57. Molecular Biology of Wilm’s Tumor: What’s in Children's Oncology Group and SIOP, XX Congress Latin American Society of Pediatric Oncology (SLAOP) Meeting, Campo Grande, Brazil, 4/2005
58. The Intergroup Hepatoma Study, 37th Congress International Society of Paediatric Oncology, Vancouver, BC, 9/2005
59. Honorary Symposium to Dr. J. Plaschkes: The Most Relevant Results of Translation and Clinical Research of the Last Two Decades, 37th Congress International Society of Paediatric Oncology, Vancouver, BC, 9/2005
60. Therapeutic Approach of Soft Tissue Sarcomas in Pediatric Patients – Controversies in Chemotherapy Treatment, Pediatric Cancer Module at the XXVI National Congress of Oncology, Acapulco Guerrero, Mexico, 10/2005
61. New Drugs in Rhabdomyosarcoma Treatment, IRS Experience, Pediatric Soft Tissue Module: Soft Tissue Sarcomas at the XXIV National Congress of Oncology, Acapulco Guerrero, Mexico, 10/2005
62. Therapeutic Approach of Soft Tissue Sarcomas in Pediatric Patients, Pediatric Soft Tissue Module: Soft Tissue Sarcomas at XXIV National Congress of Oncology, Acapulco Guerrero, Mexico, 10/2005
63. The Second International Symposium on CNS Germ Cell Tumors, University City, Los Angeles, CA, 11/2005
64. Hepatoblastoma: Treatment Results with Surgery and Chemotherapy, Institute of Pediatric Oncology (IOPat the Universidad Federal de Sao Paulo Escola Paulista de Medicine, Department of Pediatrics (UNIFESP/EPM), Sao Paulo, Brazil, 11/2006
65. Hepatoblastoma: Treatment Results with Surgery and Chemotherapy, National Congress of Oncology, Lima, Peru, 11/2006
66. Advances in the Treatment of Pediatric Germ Cell Tumors, National Congress of Oncology, Lima, Peru, 11/2006
67. Recurrent Wilms’ Tumor, Logical Venue Solution - SIOPEL, London, England, 2/2007
68. Cooperation Across Geographical & Specialty Barriers, Pathology Workshop on Pediatric Liver Tumors - SIOPEL, Gdansk, Poland, 3/2007
69. Alternativas de Tratamiento Para Pacientes con Sarcomas Renales, XXV Congreso Nacional de Oncologia, Chiapas, Mexico, 10/2007
70. Tumor de Wilms como Modelo de Exito Terapeutico, Resultados de Tratemiento, XXV Congreso Nacional de Oncologia, Chiapas, Mexico, 10/2007
71. Hepatoblastoma Irresecable, Alternativas de Tratemiento, XXV Congreso Nacional de Oncologia, Chiapas, Mexico, 10/2007
72. Relapsed Wilms’ Tumor: International cooperation is the answer, Second International Tuebingen Symposium on Pediatric Solid Tumors, Tuebingen, Germany, 12/2007
73. Sarcomas: How Should We Face Those Tumors That Don’t Respond?, SIU World Pediatric Uro-Oncology Update, Santiago, Chile, 11/2008
74. Investigation Protocols in Pediatric Uro-Oncology: Current and Future Status, SIU World Pediatric Uro-Oncology Update, Santiago, Chile, 11/2008
75. Wilms Tumor: Update on Biology and Genetics of Urogenital Tumors, SIU World Pediatric Uro-Oncology Update, Santiago, Chile, 11/2008
76. Neuroblastoma: Current role of Chemotherapy, SIU World Pediatric Uro-Oncology Update, Santiago, Chile, 11/2008
77. Future Treatment, SIOPEL, Munich, Germany, 3/2009
78. COG Studies, SIOPEL, Munich, Germany, 3/2009
79. High risk Hepatoblastoma, SIOPEL, Munich, Germany, 3/2009
80. The Role for Chemotherapy in Advanced HCC, Liver Tumor Conference - The Hospital for Sick Children, Toronto, Canada, 6/2009
81. Alveola Rhabdomyosarcoma, Latin American Society of Pediatric Oncology (SLAOP), Sao Paulo, Brazil, 10/2009
82. Second Tumor and Late Metastasis in Retinoblastoma - Is Life Term Follow-Up Required, Latin American Society of Pediatric Oncology (SLAOP), Sao Paulo, Brazil, 10/2009
83. Tumores Hepaticos: Resultados del Tratamiento con Cirugia y Quimioterapia, Hospital De Pediatria, Buenos Aires, Argentina, 3/2010
84. Sarcoma Tejidos Blandos No Rabdomiosarcoma, El Cancer Infantil en el Siglo 21, Tijuana, Mexico, 5/2010
85. Experience of COG in Hepatoblastoma, XXVIII National Congress of Oncology, Cancun, Mexico, 10/2010
86. Low Frequently Neoplasms in Children, XXVIII National Congress of Oncology, Cancun, Mexico, 10/2010
87. Pediatric Liver Tumors: The Children's Oncology Group (COG) Experience, SIOPEL - 5th International Tubingen-Symposium on Pediatric Solid Tumors, Tubingen, Germany, 3/14/2014
 
PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
1. Malogolowkin MH, Siegel SE, Strandjord S, Sather H, Hammond GH, Melphalan (L-PAM) is active in untreated neuroblastoma, American Society of Pediatric Hematology-Oncology Annual Meeting (ASPHO), Chicago, IL, 1989
2. Malogolowkin MH, Jacobs C, Horowitz RS, Weiner JM, Hammond GD, Computer Assisted Protocol Development in Cancer Clinical Trial Research, American Society for Information Science and Technology Meeting, 1990
3. Malogolowkin MH, Ortega JA, Treatment of Children with Bladder/Prostate Rhabdomyosarcoma (RMS) without Pelvic Exenteration, American Society of Clinical Oncology (ASCO) Annual Meeting , 1990
4. Malogolowkin MH, Stanley P, Daniels J, Ortega JA, Chemoembolization for Progressive Hepatoblastoma in Children, American Society of Clinical Oncology (ASCO) Annual Meeting, 1993
5. Malogolowkin MH, Feusner J, Steele DA, Lavado MG, Ortega JA, Carboplatin (CBDCA)/Etoposide (VP-16) for the Treatment of Children with High-Risk or Recurrent Wilms’ Tumor, American Society of Clinical Oncology (ASCO) Annual Meeting, 1994
6. Malogolowkin MH, Steele DA, Ortega JA, Rowland J, Scanlon KJ, Circumvention of Platinum Resistance by Azidothymidine (AZT) in Childhood Malignancies, American Association for Cancer Research (ASCR) Annual Meeting, 1994
7. Tannous R, Coccia P, Sposto R, Beckwith B, Giller R, Gyepes M, Holcomb G, Kim T, La Quaglia M, Malogolowkin MH, Stranjord S, Salvage Intensive/Sequential Chemotherapy (I/SCT) Plus Surgery (S) for Wilms Tumor (WT). A Children Cancer Group (CCG)-4921 Study Report, American Society of Clinical Oncology (ASCO) Annual Meeting, 1995
8. Malogolowkin MH, Steele D, Deegan W, Ortega J, Murphree AL, Systemic Chemotherapy for Intraocular Retinoblastoma (IO-RB), American Society of Clinical Oncology (ASCO) Annual Meeting, 1995
9. Villablanca JG, Madden T, Malogolowkin MH, Hager HK, Johansen MJ, Pharmacokinetics (PK) of Continuous Infusion High Dose Carboplatin in Children, American Society of Clinical Oncology (ASCO) Annual Meeting, 1995
10. Ortega JA, Rowland J, Monforte HL, Malogolowkin M, Triche T, Therapeutic Implications of Presence of differentiated Rhabodmyoblasts at the End of Therapy (TX) for Childhood Pelvic Rhabdomyosarcoma (RMS), American Society of Clinical Oncology (ASCO) Annual Meeting, 1996
11. Malogolowkin MH, Ortega JA, Carcich S, Steel DA, Tishler D, Franklin J, Nandy P, Periclou A, Cohen LJ, Avramis VI, Successful CSF Asparaginase (Asn) Depletion Following Administration of PEG-Asparaginase (PEG-asnase) in Children with Acute Lymphoblastic Leukemia (ALL) with Isolated CNS Relapse, American Society of Clinical Oncology (ASCO) Annual Meeting, 1998
12. Ortega JA, Rios P, Malogolowkin, MH, Successful Treatment of Hepatoblastoma (HB) with Ann Intensified Platinum Regimen, American Society of Clinical Oncology (ASCO) Annual Meeting, 1998
13. Rowland JM, Shu Q, Malogolowkin MH, Kuroda C, Peters J, Multidrug Resistance Gene Expression in Stage 4 Wilms’ Tumors: Correlation with Outcome, Annual Meeting of the Society for Pediatric Pathology, 1998
14. Malogolowkin MH, Sposto R, Grovas L, Breneman J, Womer R, Ortega JA, Lack of Improvement in Survival of Children with Metastatic Rhabdomyosarcoma (RMS) Treated with Intensive Therapy Followed by Stem Cell Transplant (SCT) for Control of Minimal Residual Disease, American Society of Clinical Oncology (ASCO) Annual Meeting, 1999
15. Green DM, Breslow NE, Beckwith B, Ritchey ML, Shamberger RC, Haase GM, D’Angio GJ, Donaldson MH, Grundy PE, Weetman RM, Coopes MH, Malogolowkin MH, Treatment with nephrectomy only for small, stage I/favorable histology Wilms tumor. A Report from the National Wilms Tumor Study Group, American Society of Clinical Oncology (ASCO) Annual Meeting, 2000
16. Tannous R, Giller R, Holmes E, Kim T, La Quaglia M, Malogolowkin MH, Montebello J, Sposto R, Green D, Coccia P, Intensive Therapy for High Risk (HR) Relapsed Wilms Tumor (WT). A CCG-4921/POG-9445 Study Report, American Society of Clinical Oncology (ASCO) Annual Meeting, 2000
17. Malogolowkin MH, Bergman T, Seibel N, Dome J, Coccia P, Coppes M, Breslow N, Outcome and Prognostic Factors (PF) for Patients with Recurrent wilms Tumor (R-WT) – National Wilms Tumor Study –3 and 4 (NWTS 3,4), American Society of Clinical Oncology (ASCO) Annual Meeting, 2001
18. Van Tornout JM, Butturini A, Mascarenhas L, Malogolowkin MH, Siegel SE, Does race affect outcome in pediatric metastatic sarcoma?, American Society of Clinical Oncology (ASCO) Annual Meeting, 2002
19. Jubran RF, Marachelian A, Malogolowkin MH, Outcome of patients with Langerhan’s cell histiocytosis with bone involvement, American Society of Pediatric Hematology-Oncology (ASPHO) Annual Meeting, 2002
20. Del Toro G, Malogolowkin MH, Giller R, London W, Davenport V, Bergeron S, Cairo MS, Alphafetoprotein (AFP) expression in pediatric solid tumors: a potential role for the use of targeted radioimmunotherapy with 90-Y-hafp31 igg1, 2nd International Congress on Monoclonal Antibodies in Cancer, 2002
21. Marina N, Malogolowkin MH, London WB, Frazier AL, Rescorla F, Billmire DF, Davis M, Perlman E, Giller R, Lauer S, Amifostine does not protect against the ototoxicity associated with high-dose cisplatin, etoposide and bleomycin (HD-PEB) in pediatric germ cell tumors (PGCT): A PGCT Intergroup Study, American Society of Clinical Oncology (ASCO) Annual Meeting, 2003
22. Jubran RF, Marachelian A, Dorey F, Malogolowkin MH, Predictors of outcome in children with Langerhans cell histiocytosis, American Society of Clinical Oncology (ASCO) Annual Meeting , 2004
23. Malogolowkin MH, Katzenstein, HM, Krailo M, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Castleberry R, Intensive versus standard platinum therapy for the treatment of children with hepatoblastoma (HB): A report of the Intergroup Hepatoblastoma Study P9645, American Society of Clinical Oncology (ASCO) Annual Meeting, 2004
24. Katzenstein HM, Chang K, Krailo M, Bowman L, Greffe B, Castleberry R, Malogolowkin MH, A randomized study of platinum based chemotherapy with or without amifostine for the treatment of children with hepatoblastoma (HB): A report of the Intergroup Hepatoblastoma Study P9645, American Society of Clinical Oncology (ASCO) Annual Meeting, 2004
25. Green DM, Malogolowkin, MH, Cotton C, Math M, Breslow N, Perlman E, Miser J, Ritchey M, Thomas P, Grundy P, D’Angio G, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Chearer P, Coccia P, Kletzel M, Macklis R, Treatment of Wilms Tumor Relapsing After Initial Treatment with Vincristine and Actinomycin D. A Report from the National Wilms Tumor Study (NWTS) Group, American Society of Clinical Oncology (ASCO) Annual Meeting, 2005
26. Malogolowkin MH, Green DM, Cotton C, Breslow N, Perlman E, Miser J, Ritchey M, Thomas P, Kletzel M, Coccia PF, Treatment of Wilms Tumor Relapsing After Initial Treatment with Vincristine, Actinomycin D and Doxorubicin. A Report from the National Wilms Tumor Study (NWTS) Group, American Society of Clinical Oncology (ASCO) Annual Meeting, 2005
27. Malogolowkin MH, London WB, Giller R, Davis MM, Cullen J, Olson T, Site of Metastases Does Not Influence the Clinical Outcome of Children with Metastatic Germ Cell Tumors (GCT). A Report from the Children's Oncology Group (COG), American Society of Clinical Oncology (ASCO) Annual Meeting, 2006
28. Malogolowkin, MH, Kazenstein H, Krailo M, Rowland J, Haas J, Meyers R, Finegold M, Complete surgical resection is curative children with pure fetal histology hepatoblastoma (PFH): A report of the Children's Oncology Group (COG), American Society of Clinical Oncology (ASCO) Annual Meeting, 2008
29. Malogolowkin MH, Krailo M, Frazier LA, Olson TA, Study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high-risk germ cell tumors. A Children's Oncology Group (COG) Report, American Society of Clinical Oncology (ASCO) Annual Meeting, 2009
30. Mascarenhas L, Armenian S, Harrington JL, Mahmoud H, Sposto R, Malogolowkin MH, Phase I trial of oxaliplatin and doxorubicin in children and adolescents with recurrent solid tumors, American Society of Clinical Oncology (ASCO) Annual Meeting, 2010
31. Sanchez-Diaz PC, Chen TL, Meyers R, Malogolowkin MH, Hung JY, Tomlinson GE, Sorafenib, gamma-secretase inhibitor and bortezomib as potential therapeutic agents for hepatoblastoma, American Society of Clinical Oncology (ASCO) Annual Meeting, 2010
32. Emami CN, Petrosyan M, Malogolowkin M, Stein JE, Central liver resection is a feasible substitute for transplantation in pediatric cases of Hepatoblastoma, American Pediatric Surgical Association (APSA) Annual Meeting, Palm Desert, CA, 5/2011
33. Malogolowkin MH, Spreafico F, Dome JS, Breslow N, van Tinteren NH, Pritchard-Jones K, van den Heuvel, Bergeron MC, De Kraker J, Graf N, Incidence and outcomes of patients with late recurrence of Wilms tumor (WT): The international experience, American Society of Clinical Oncology (ASCO) Annual Meeting, 2011
34. Mullen EA, James R, Steacy J, James I ,Green DM, Norkool P, Conrad V, Fernandez H, Malogolowkin MH, Dome JS, The impact of surveillance imaging on overall survival in patients with recurrent wilms tumor: A report from the children's oncology group, American Society of Clinical Oncology (ASCO) Annual Meeting, 2011
35. Venkatramani R, Wang L, Malvar J, Sposto R, Malogolowkin MH, Mascarenhas L, Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma, American Society of Pediatric Hematology-Oncology (ASPHO) Annual Meeting, 2011
36. Malogolowkin MH, Czauderna P, Haberle B, Hiyama E, Schmid I, Krailo M, Maibach R, Katzenstein H, Perilongo G, Aronson DC, VonSchweinitz D, Meyers RL, Hepatocellular Carcinoma in Children and Adolescents: The International Therapeutic Experience, American Pediatric Surgical Association (APSA) - International Society of Paediatric Surgical Oncology (IPSO) 43rd Annual Meeting - Oncology Research Session, San Antonio, TX, 2012
 
International
1. Malogolowkin I, Malogolowkin MH, Leal KJ, Larvemia – A Case Report, XI Brazilian Congress of Clinical Pathology, Brazil, 1977
2. Castro P, Malogolowkin MH, Lemle A, Spirography of non-smokers and healthy populations of two areas with different degrees of pollution in Rio de Janeiro, IV Congress of the Brazilian Pneumology Society, Brazil, 1978
3. Castro P, Malogolowkin MH, Rocha ML, Lemle A, Pulmonary Function of South American champion Rowers, XXI World Congress of Sports Medicine, Brasilia, Brazil, 1978
4. Castro P, Malogolowkin MH, Lemle A, Correlation between minimal respiratory symptoms and flow-volume curve in socio-culturally privileged populations, IV Congress of the Brazilian Pneumology Society, Brazil, 1978
5. Malogolowkin MH, Rocha ML, Figueiredo PR, Lemle A, Pulmonary Lactate Removal in Athletes during Exercise, World Congress of Sports Medicine, Brasilia, Brazil, 1978
6. Castro P, Malogolowkin MH, Rocha ML, Lemle A, Pulmonary function tests in rowers, sprinters and distance runners, V Congress of Brazilian Sports Medicine and IV International Meeting of Sport Medicine, Sao Paulo, Brazil, 1979
7. Malogolowkin MH, Castro P, Rocha ML, Influence of hypothermia, anoxia and effort in swimming ECG test in rats, V Congress of Brazilian Sports Medicine and IV International Meeting of Sport Medicine, Sao Paulo, Brazil, 1979
8. Malogolowkin MH, Castro P, Lemle A, Tests spirograph and flow-volume curve in young adults with asthma, II Pan American Congress of Diseases of the Chest, Rio de Janeiro, Brazil, 1980
9. Malogolowkin MH, Ortega JA, Gonzales O, Siegel SE, Frequency of Malignancy at Recurrence in Teratomas with Immature Elements, International Society of Paediatric Oncology (SIOP) XIX Meeting , Jerusalem, 1987
10. Malogolowkin MH, Ortega JA, Effective Treatment for Advanced Ewing’s and Primitive Neuroectodermal Tumors (PNET), International Society of Paediatric Oncology (SIOP) XX Meeting, Prague, 1989
11. Murphree AL, Malogolowkin MH, Gomer CJ, Sato J, Alternatives to the Use of External Beam Radiotherapy in Bilateral Retinoblastoma, International Council of Ophthalmology (ICO) Annual Meeting, Toronto, Canada, 1994
12. Ortega JA, Rowland J, Monforte HL, Malogolowkin MH, Triche T, Outcome of Children with Presence of Differentiated Rhabdomyoblasts at the End of Therapy (TX) for Rhabdomyosarcoma (RMS), International Society of Paediatric Oncology (SIOP) XXVII Meeting, Vienna, Austria, 1996
13. Roebuck DJ, Malogolowkin MH, Kovanlikaya A, Bottcher M, Gilsanz V, Ortega J, Defect in Bone Mineralization Following Ifosfamide (IF) Treatment for Childhood Sarcomas, International Society of Paediatric Oncology (SIOP) XXVII Meeting, Vienna, Austria, 1996
14. Shaul D, Scheer B, Boody B, Malogolowkin, MH, Mason M, Mahour GH, Risk Factors for Early Infection of Central Venous Catheters in Pediatric patients, Annual Meeting of the Pacific Association of Pediatric Surgeons, 1998
15. Marina NM, London WB, Lauer SL, Giller R, Cushing B, Malogolowkin MH, Castleberry RC, Womer R, Prognostic Factors in Pediatric Patients with Extragonadal Germ Cell Tumors: A Pediatric Oncology Group and Children's Cancer Group Germ Cell Tumor Study, International Society of Paediatric Oncology (SIOP) XXXII Meeting, Amsterdam, The Netherlands, 2000
16. Jubran RF, Marachelian A, Malogolowkin MH, Outcome of patients with Langerhan’s cell histiocytosis with bone involvement, XVIII Annual Meeting of the Histiocyte Society, Porto, Portugal, 2003
17. Malogolowkin MH, Brain Metastases from Childhood Systemic Germ Cell Tumors, The Second International Symposium of CNS Germ Cell Tumors, Los Angeles, CA, 2005
18. Malogolowkin MH, Katzenstein HM, Krailo M, Feusner, J, Reynolds, M, Quinn JJ, Finegold M, Ortega J, Outcome of Patients with Recurrent or Progressive Hepatoblastoma: A Report of the Intergroup Liver tumor Study INT-0098, International Society of Paediatric Oncology (SIOP) XXXVII Annual Meeting, Vancouver, Canada, 2005
19. Madigan C, Malogolowkin MH, Mascarenhas L, Extra-Cranial Rhabdoid Tumor in Childhood: A Single Institution Experience, International Society of Paediatric Oncology (SIOP) XXXVII Annual Meeting Abstracts, Vancouver, Canada, 2005
20. Malogolowkin MH, London W, Frazier L, Olson T, Brain Metastases in Children with High Risk Germ Cell Tumors (GCT): A report of the Children’s Oncology Group (COG), International Society of Paediatric Oncology (SIOP) XXXX Meeting, Berlin, Germany, 2008
21. Butturini A, Mascarenhas L, Lavey R, Malogolowkin MH, Ortega JA, Reynolds P, Seeger, R, Siegel S, First Meeting of the Israeli Society of Pediatric Hematology-Oncology, Dead Sea, Israel, 2010
22. Frazier L, Cullen, Krailo M, Rodriguez-Galindo C, Rescorla F, Ross J, Amatruda J, Egler R, Malogolowkin MH, Olson T, Davis M, Schlatter M, Billmire D, Stage I Ovarian Germ Cell Tumors: Outcome of a Watch and Wait Strategy, International Society of Paediatric Oncology (SIOP) XXXXII Meeting, Boston, MA, 2010
 
COMMITTEE SERVICE:
Medical College
1997 - 2011 Ad Hoc Member, Committee of the Pharmacy and Therapeutics Committee on Antiemetic, University of California, Los Angeles
1998 - 2000 Member, Clinical Laboratory Compliance Committee, University of California, Los Angeles
1998 - 2000 Member, Blood and Blood Derivatives Subcommittee, University of California, Los Angeles
1998 - 2000 Member, Quality Assurance Committee, Jonsson Comprehensive Cancer Center, University of California Los Angeles
 
Hospital
1993 - 1994 Member, Infection Control Committee, Children's Hospital Los Angeles
1993 - 1997 Member, Core Pediatric Seminars, Children's Hospital Los Angeles
1994 - 1996 Member, Bereavement Team, Children's Hospital Los Angeles
1994 - 1995 Member, Residency Review Committee, Children's Hospital Los Angeles
1994 - 1997 Member, Committee on Clinical Investigations (IRB), Children's Hospital Los Angeles
1994 - 1995 Member, Professional Advisory/Quality Review Committee, Children's Hospital Los Angeles
1994 - 1995 Member, Nutrition Committee, Children's Hospital Los Angeles
2000 - 2001 Co-Chair, Case Management Functional Project Team, Children's Hospital Los Angeles
2000 - 2011 Interviewer/Reviewer, Fellow Recruitment Committee, Hematology-Oncology, Pediatrics, Children's Hospital Los Angeles
2000 - 2001 Co-Chair, Case Management Functional Project Team, Children's Hospital Los Angeles
2002 - 2011 Member, CERNER Implementation Leadership Group, Children's Hospital Los Angeles
2005 - 2011 Vice-Chair, Ambulatory Care Services Committee, Children's Hospital Los Angeles
2009 - 2011 Member, Finance Committee, University Children's Medical Group (UCMG), Children's Hospital Los Angeles
2009 - 2011 Member, Board of Directors, University Children's Medical Group (UCMG), Children's Hospital Los Angeles
 
MEDICAL COLLEGE TEACHING ACTIVITIES:
Resident and Fellow Education
4/16/2012 Pediatric Hematology/Oncology/BMT Fellows Lecture Series - Renal Tumors
 
EXTRAMURAL TEACHING (e.g. at Marquette, UWM, etc.):
Community/Lay Public
1989 Children's Hospital Los Angeles, Teen-Line Program, Ronald McDonald House - Childhood Cancer: An Overview
1990 Children's Hospital Los Angeles, IMPACT – Information and Management Programs Addressing Cancer Treatments (in English and Spanish) - Childhood Cancer Treatments: What Parents Should Know About Chemotherapy and Clinical Trials
1990 Children's Hospital Los Angeles, Teen-Line Program, Ronald McDonald House - Childhood Cancer: An Overview
1991 Children's Hospital Los Angeles, Siblings Program, Division of Hematology-Oncology - Cancer Overview
1993 Children's Hospital Los Angeles, Teen Impact Program, Division of Hematology-Oncology - Overview of Pediatric Cancer
1993 Children's Hospital Los Angeles, Sibling Day, Division of Hematology-Oncology - Pediatric Cancer
1997 Children's Hospital Los Angeles, Family Matters Support Team, Division Hematology-Oncology - Understanding Cancer in Children and Teen
 
Medical Student Education
1990 - 1997 Children's Hospital Los Angeles, Core Pediatric Seminars presented to University of Southern California Medical Students
 
Resident and Fellow Education
1995 Children's Hospital Los Angeles, Surgical Resident Presentation - Wilms Tumor
1995 Children's Hospital Los Angeles, Surgical Resident Presentation - Rhabdomyosaracomas
1996 Children's Hospital Los Angeles, Surgical Resident Presentation - Liver Tumors
1996 Children's Hospital Los Angeles, Surgical Resident Presentation - Wilms Tumor
1997 Children's Hospital Los Angeles, Surgical Resident Presentation - Wilms Tumor
2000 - 2011 Children's Hospital Los Angeles, Ongoing participation in House Staff noon conferences, M&M, Pediatric Grand Rounds
1/2005 Children's Hospital Los Angeles, Hematology-Oncology Fellows Lecture - Approaches to Soft Tissue Tumors
7/2005 Children's Hospital Los Angeles, New Fellows Orientation, Division of Hematology-Oncology - Bone and Soft Tissue Tumors
2006 Children's Hospital Los Angeles, New Fellows Orientation, Division of Hematology-Oncology - Soft Tissue Tumors
1/2008 Children's Hospital Los Angeles, Hematology-Oncology Fellows Lecture - Liver Tumors
1/2008 Children's Hospital Los Angeles, Hematology-Oncology Fellows Lecture - Renal Tumors
1/2009 Children's Hospital Los Angeles, Hematology-Oncology Fellows Lecture - Germ Cell Tumor
2/2010 Children's Hospital Los Angeles, Hematology-Oncology Fellows Lecture - Update on Biology, Genetics and Treatment of Wilms Tumor
1/2011 Children’s Hospital Los Angeles, Pediatric Surgery Core Lecture Series - Hepatic and Germ Cell Tumors in Children
5/14/2013 Medical College, Pediatric Hematology/Oncology/BMT Fellows Lecture Series-Germ Cell Tumors
 
Continuing Medical Education
1986 Children's Hospital Los Angeles, Hematology-Oncology Grand Rounds - Hematological Consequences of Storage Diseases
1987 Children's Hospital Los Angeles, Laboratory Medicine Seminar - Storage Disease in Hematology
1987 Children's Hospital Los Angeles, Hematology-Oncology Grand Rounds - Teratomas
1988 Children's Hospital Los Angeles, Hematology-Oncology Grand Rounds - Soft Tissue Sarcomas
1988 Children's Hospital Los Angeles, Oncology Nursing Staff Presentation - Differential Diagnosis of Anemia
1988 Children's Hospital Los Angeles, Hematology-Oncology Grand Rounds - Rhabdomyosarcomas
1988 Children's Hospital Los Angeles, Nutrition Staff Seminar - Childhood Cancer: An Overview
1988 Children's Hospital Los Angeles, IMPACT – Information and Management Programs Addressing Cancer Treatments (in English and Spanish) - Childhood Cancer: An Overview
1991 Children's Hospital Los Angeles, Pediatric Grand Rounds - Home Health Care
1991 Children's Hospital Los Angeles, Nursing Staff Presentation - Tumor Lysis Syndrome, Basics of Oncology
1991 University of Southern California, Tumor Registrar Training Program - Childhood Cancer
1991 Children's Hospital Los Angeles, Nursing Staff Presentation - Blood Component Therapy, Basics of Oncology
1992 Children's Hospital Los Angeles, Cancer Clinical Trials Rounds, Division of Hematology-Oncology - Acute Non-Lymphocytic Leukemia
1992 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
1993 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
1994 Children's Hospital Los Angeles, Grand Rounds, Division of Hematology-Oncology - Multiple Drug Resistance
1994 Children's Hospital Los Angeles, Nursing Staff Presentation - Cancer Overview, Basics of Oncology
1994 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
1995 Children's Hospital Los Angeles, Nursing Staff Presentation - Principles of Chemotherapy, Chemotherapy Class
1995 University of Southern California, Tumor Registrar Training Program - Late Effects of Pediatric Cancer
1995 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
1996 University of Southern California, Tumor Registrar Training Program - Late Effects in Pediatric Cancer
1996 Children's Hospital Los Angeles, Nursing Staff Chemotherapy Class - Blood Products and Blood Transfusion
1996 Children's Hospital Los Angeles, Department of Adolescent Medicine Presentation - Gonadal Tumors in Adolescents
1996 Children's Hospital Los Angeles, Department of Adolescent Medicine Presentation - Late Effects in Pediatric Cancer
1996 Children's Hospital Los Angeles, Division of Infectious Disease Presentation - Novel Approaches for Treatment of Liver Tumors
1996 Children's Hospital Los Angeles, Nursing Staff Chemotherapy Class - Principles of Chemotherapy
1996 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
1996 Children's Hospital Los Angeles, Nursing Staff Chemotherapy Class - Principles of Chemotherapy
1997 University of Southern California, Tumor Registrar Training Program - Late Effects in Pediatric Cancer
1997 Children's Hospital Los Angeles, Surgical Resident Presentation - Wilms Tumor
1997 Children's Hospital Los Angeles, Leukemia-Lymphoma Program Meeting, Division of Hematology-Oncology - CNS Leukemia
1997 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
1997 Children's Hospital Los Angeles, Surgical Conference - New Therapeutic Approaches to Liver Tumors
1997 Children's Hospital Los Angeles, Nursing Staff Chemotherapy Class - Principles of Chemotherapy
1997 Children's Hospital Los Angeles, Nursing Staff Presentation - Overview of Pediatric Cancer
1998 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
1999 University of Southern California, Tumor Registrar Training Program - The Differences Between Pediatric and Adult Abdominal Tumors
1999 University of Southern California, Tumor Registrar Training Program - Late Effects in Pediatric Cancer
2000 - 2011 Children's Hospital Los Angeles, Ongoing participation in Oncology weekly Grand Rounds and Tumor Board
2000 University of Southern California, Tumor Registrar Training Program - Overview of Pediatric Cancer
2000 University of Southern California, Tumor Registrar Training Program - Late Effects of Childhood Cancer
9/2001 Children's Hospital Los Angeles, Hematology-Oncology Orientation, 3 East Nurses - Tumor Lysis and DIC
2001 University of Southern California, Tumor Registrar Training Program - Childhood Cancer and Late Effects of Therapy in Childhood Cancer
12/2004 Children's Hospital Los Angeles, Hematology-Oncology Nursing Presentation - Childhood Cancer
8/2007 Children's Hospital Los Angeles, Hem-Onc Update, Division of Hematology-Oncology - Pediatric Bone & Soft Tissue Tumors
1/2008 Children's Hospital Los Angeles, Update, Division of Hematology-Oncology - Wilms Tumor – A Successful Therapeutic Model in Pediatric Cancer
2/2010 Children's Hospital Los Angeles, Pediatric Surgery M&M Conference - Pediatric Germ Cell Tumors
8/2010 Children's Hospital Los Angeles, Hematology-Oncology BMT Update - Solid Tumor Update
1/2011 Children’s Hospital Los Angeles, Hematology-Oncology Grand Rounds - Pediatric Liver Tumors-A Model of Clinical Research and International Cooperation
9/2011 Children’s Hospital Los Angeles, Grand Rounds - Pediatric Liver Tumors – A Model of Clinical Research and International Cooperation
 
PROFESSIONAL DEVELOPMENT:
2012 - 2013 MCW/UWM Faculty Leadership Development Program


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Castro P, Malogolowkin MH, Lemle A. Correlation between minimal respiratory symptoms and flow volume curve in socio culturally privileged populations. J Pneumologia. 1978;4(4):205
2. Malogolowkin MH, Rocha ML, Figueiredo PR, Lemle A. Lactate Removal in Athletes during Exercise. Rev Bras Ed Fisica. 1979;5:138-142
3. Castro P, Malogolowkin MH, Rocha ML, Lemle A. Pulmonary function in rowers, sprinters, and distance runners. J Bras Medicina. 1980;39(6):45-58
4. Malogolowkin MH, Ortega JA Rhabdomyosarcoma of childhood. Pediatr Ann. 1988 Apr;17(4):251, 254-268
5. Malogolowkin MH, Ortega JA, Krailo M, Gonzalez O, Mahour GH, Landing BH, Siegel SE Immature teratomas: identification of patients at risk for malignant recurrence. J Natl Cancer Inst. 1989 Jun;81(11):870-874
6. Malogolowkin MH, Horowitz RS, Ortega JA, Siegel SE, Hammond GD, Weiner JM Tracing expert thinking in clinical trial design. Comput Biomed Res. 1989 Apr;22(2):190-208
7. Malogolowkin MH, Horowitz RS, Ortega JA, Siegel SE, Hammond GD, Weiner JM Idea Analysis: A New Approach in Using Scientific Literature. International Journal of Man Machine Studies. 1989;31(5):573-587
8. Malogolowkin MH, Mahour GH, Krailo M, Ortega JA Germ cell tumors in infancy and childhood: a 45-year experience. Pediatr Pathol. 1990;10(1-2):231-241
9. Weiner JM, Horowitz RS, Malogolowkin MH, Weiner RE, Hammond GD Microcomputer Preparation of Scientific Literature Reviews. Proceedings 53rd Am Soc. Information Sciences, 1990;27:181-191
10. Ablin AR, Krailo MD, Ramsay NK, Malogolowkin MH, Isaacs H, Raney RB, Adkins J, Hays DM, Benjamin DR, Grosfeld JL Results of treatment of malignant germ cell tumors in 93 children: a report from the Children's Cancer Study Group. J Clin Oncol. 1991 Oct;9(10):1782-1792
11. Chang D, Liem L, Malogolowkin M A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients. Pediatr Infect Dis J. 1994 Nov;13(11):969-974
12. Murphree AL, Villablanca JG, Deegan WF 3rd, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996 Nov;114(11):1348-1356
13. Shaul DB, Scheer B, Rokhsar S, Jones VA, Chan LS, Boody BA, Malogolowkin MH, Mason WH Risk factors for early infection of central venous catheters in pediatric patients. J Am Coll Surg. 1998 Jun;186(6):654-658
14. Parisi MT, Fahmy JL, Kaminsky CK, Malogolowkin MH Complications of cancer therapy in children: a radiologist's guide. Radiographics. 1999 Mar-Apr;19(2):283-297
15. Ortega JA, Rowland J, Monforte H, Malogolowkin M, Triche T Presence of well-differentiated rhabdomyoblasts at the end of therapy for pelvic rhabdomyosarcoma: implications for the outcome. J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):106-111
16. Malogolowkin MH, Stanley P, Steele DA, Ortega JA Feasibility and toxicity of chemoembolization for children with liver tumors. J Clin Oncol. 2000 Mar;18(6):1279-1284
17. Silva ME, Malogolowkin MH, Hall TR, Sadeghi AM, Krogstad P Mycotic aneurysm of the thoracic aorta due to Aspergillus terreus: case report and review. Clin Infect Dis. 2000 Nov;31(5):1144-1148
18. Green DM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Perlman E, Donaldson M, Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer P, Coccia P, Kletzel M, Thomas PR, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 2001 Sep;19(17):3719-3724
19. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. J Clin Oncol. 2002 Jun;20(12):2789-2797
20. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003 Apr;97(8):2006-2012
21. Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grundy P, Coppes MJ Management of Wilms' tumour: current practice and future goals. Lancet Oncol. 2004 Jan;5(1):37-46
22. Jubran RF, Marachelian A, Dorey F, Malogolowkin M Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005 Jul;45(1):37-42
23. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM, National Wilms Tumor Study Group Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005 Oct;23(29):7312-7321
24. Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA, Children's Oncology Group Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study. Cancer. 2005 Aug;104(4):841-847
25. Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006 May;24(15):2352-2358
26. Marina N, London WB, Frazier AL, Lauer S, Rescorla F, Cushing B, Malogolowkin MH, Castleberry RP, Womer RB, Olson T Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study. J Clin Oncol. 2006 Jun;24(16):2544-2548
27. Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol. 2006 Jun;24(18):2879-2884
28. Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol. 2006 Jun;28(6):342-345
29. Tcheng WY, Said J, Hall T, Al-Akash S, Malogolowkin M, Feig SA Post-transplant multiple myeloma in a pediatric renal transplant patient. Pediatr Blood Cancer. 2006 Aug;47(2):218-223
30. Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2007 May;48(5):493-499
31. Yoon JM, Burns RC, Malogolowkin MH, Mascarenhas L Treatment of infantile choriocarcinoma of the liver. Pediatr Blood Cancer. 2007 Jul;49(1):99-102
32. Meyers RL, Katzenstein HM, Malogolowkin MH Predictive value of staging systems in hepatoblastoma. J Clin Oncol. 2007 Feb;25(6):737; author reply 737-738
33. Madigan CE, Armenian SH, Malogolowkin MH, Mascarenhas L Extracranial malignant rhabdoid tumors in childhood: The Children's Hospital Los Angeles experience. Cancer. 2007 Nov;110(9):2061-2066
34. Antoneli CB, Ribeiro KB, Rodriguez-Galindo C, Soares FA, Arias VA, Novaes PE, Chojniak MM, Malogolowkin M The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J Pediatr Hematol Oncol. 2007 Oct;29(10):700-704
35. Meyers RL, Katzenstein HM, Krailo M, McGahren ED 3rd, Malogolowkin MH Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg. 2007 Dec;42(12):2050-2056
36. Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D, National Wilms Tumor Study Group Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008 Feb;50(2):236-241
37. Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, Ortega JA Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol. 2008 May;26(14):2379-2383
38. Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009 Dec;53(6):1016-1022
39. Chen TT, Rakheja D, Hung JY, Hornsby PJ, Tabaczewski P, Malogolowkin M, Feusner J, Miskevich F, Schultz R, Tomlinson GE Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. Pediatr Blood Cancer. 2009 Dec;53(6):1040-1047
40. Katzenstein HM, Chang KW, Krailo M, Chen Z, Finegold MJ, Rowland J, Reynolds M, Pappo A, London WB, Malogolowkin M, Children's Oncology Group Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group. Cancer. 2009 Dec;115(24):5828-5835
41. Spreafico F, Pritchard Jones K, Malogolowkin MH, Bergeron C, Hale J, de Kraker J, Dallorso S, Acha T, de Camargo B, Dome JS, Graf N Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther. 2009 Dec;9(12):1807-1815
42. Shamberger RC, Anderson JR, Breslow NE, Perlman EJ, Beckwith JB, Ritchey ML, Haase GM, Donaldson M, Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer PD, Kletzel M, Thomas PR, Macklis R, Huff V, Weeks DA, Green DM Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Ann Surg. 2010 Mar;251(3):555-558
43. Beaty O 3rd, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep;55(3):440-445
44. Gupta AA, Gerstle JT, Ng V, Wong A, Fecteau A, Malogolowkin MH, Meyers RL, Grant D, Grant RM Critical review of controversial issues in the management of advanced pediatric liver tumors. Pediatr. Blood Cancer. 2011,56:1013–1018
45. Venkatramani R, Ma NS, Pitukcheewanont P, Malogolowkin MH, Mascarenhas L Gorham's disease and diffuse lymphangiomatosis in children and adolescents. Pediatr Blood Cancer. 2011 Apr;56(4):667-670
46. Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, Finegold MJ Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group. J Clin Oncol. 2011 Aug;29(24):3301-3306
47. Venkatramani R, Wang L, Malvar J, Dias D, Sposto R, Malogolowkin MH, Mascarenhas L Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatr Blood Cancer. 2012 Sep;59(3):493-498
48. Malogolowkin MH, Katzenstein HM, Krailo M, Meyers RL Treatment of hepatoblastoma: the North American cooperative group experience. Front Biosci (Elite Ed). 2012;4:1717-1723
49. Gilsanz V, Hu HH, Smith ML, Goodarzian F, Carcich SL, Warburton NM, Malogolowkin M The depiction of brown adipose tissue is related to disease status in pediatric patients with lymphoma. AJR Am J Roentgenol. 2012 Apr;198(4):909-913
50. Venkatramani R, Furman WL, Fuchs J, Warmann SW, Malogolowkin MH Current and future management strategies for relapsed or progressive hepatoblastoma. Paediatr Drugs. 2012 Aug;14(4):221-232
51. Perilongo G, Malogolowkin M, Feusner J Hepatoblastoma clinical research: Lessons learned and future challenges. Pediatr Blood Cancer. 2012 Nov;59(5):818-821
52. Venkatramani R, Malogolowkin MH, Wang L, Mascarenhas L Pleuropulmonary Blastoma: A Single-institution Experience. J Pediatr Hematol Oncol. 2012 Jul;34(5):e182-185
53. Puumala SE, Ross JA, Feusner JH, Tomlinson GE, Malogolowkin MH, Krailo MD, Spector LG Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group. Hum Reprod. 2012 Jun;27(6):1649-1656
54. Ha TC, Spreafico F, Graf N, Dallorso S, Dome JS, Malogolowkin M, Furtwängler R, Hale JP, Moroz V, Machin D, Pritchard-Jones K An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour. Eur J Cancer. 2013 Jan;49(1):194-210
55. Mascarenhas L, Malogolowkin M, Armenian SH, Sposto R, Venkatramani R A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors. Pediatr Blood Cancer. 2013 Jul;60(7):1103-1107
56. Rodriguez-Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G, on behalf of the COG Rare Tumors Disease Committee Children's Oncology Group's 2013 blueprint for research: Rare tumors. Pediatr Blood Cancer. 2013 Jun;60(6):1016-1021
57. Dome JS, Fernandez CV, Mullen EA, Kalapurakal JA, Geller JI, Huff V, Gratias EJ, Dix DB, Ehrlich PF, Khanna G, Malogolowkin MH, Anderson JR, Naranjo A, Perlman EJ, on behalf of the COG Renal Tumors Committee Children's Oncology Group's 2013 blueprint for research: Renal tumors. Pediatr Blood Cancer. 2013 Jun;60(6):994-1000
58. Browning M, Mortland L, Malogolowkin M. Chemotherapy in pediatric bone and soft-tissue sarcomas. Current Orthopaedic Practice, 2013 May/June;24(3):239-247
59. Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Häberle B, Tomlinson GE, Katzenstein HM, Malogolowkin MH, von Schweinitz D, Krailo M, Feusner JH Outcomes for patients with congenital hepatoblastoma. Pediatr Blood Cancer. 2013 Nov;60(11):1817-1825
60. Malogolowkin M, Spreafico F, Dome JS, van Tinteren H, Pritchard-Jones K, van den Heuvel-Eibrink MM, Bergeron C, de Kraker J, Graf N, On behalf of the COG Renal Tumors Committee and the SIOP Renal Tumor Study Group Incidence and outcomes of patients with late recurrence of Wilms' tumor. Pediatr Blood Cancer. 2013 Oct;60(10):1612-1615
61. Malogolowkin MH, Krailo M, Marina N, Olson T, Frazier AL Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: A report of the children's oncology group (COG). Pediatr Blood Cancer. 2013 Oct;60(10):1602-1605
62. Venkatramani R, Malogolowkin M, Davidson TB, May W, Sposto R, Mascarenhas L A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013;8(7):e68416
63. Johnson KJ, Williams KS, Ross JA, Krailo MD, Tomlinson GE, Malogolowkin M, Feusner JH, Spector LG Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: A report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1837-1843
64. López-Terrada D, Alaggio R, de Dávila MT, Czauderna P, Hiyama E, Katzenstein H, Leuschner I, Malogolowkin M, Meyers R, Ranganathan S, Tanaka Y, Tomlinson G, Fabrè M, Zimmermann A, Finegold MJ Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014 Mar;27(3):472-491
65. Venkatramani R, Malogolowkin MH, Mascarenhas L Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab. Pediatr Blood Cancer. 2014 Apr;61(4):756-759
66. Green DM, Breslow NE, D'Angio GJ, Malogolowkin MH, Ritchey ML, Evans AE, Beckwith JB, Perlman EJ, Shamberger RC, Peterson S, Grundy PE, Dome JS, Thomas PR, Kalapurakal JA Outcome of patients with stage II/favorable histology wilms tumor with and without local tumor spill: A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2014 Jan;61(1):134-139
67. Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr. 2014 Feb;26(1):19-28
68. Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C, Frazier AL Surveillance After Initial Surgery for Pediatric and Adolescent Girls With Stage I Ovarian Germ Cell Tumors: Report From the Children's Oncology Group. J Clin Oncol. 2014 Feb;10,32(5):465-470
69. Czauderna P, Beate H, Hiyama E, Krailo M, Maibach R, Rinaldi E, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, Rangaswami A, von Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R; Children's Hepatic tumors International Collaboration (CHIC) as a model of international global cooperation and clinical research in pediatric rare tumors. The Lancet[accepted for publication]2013
70. Gonzalez-Morkos B, Zavala O, Malogolowkin M, Kuperberg A The Teen Impact Experience: A Webcast Pilot Project for Teens With Cancer and Blood Diseases. J Pediatr Oncol Nurs. 2014 Jun 9: 1-5
71. Venkatramani R, Spector LG, Georgieff M, Tomlinson G, Krailo M, Malogolowkin M, Kohlmann W, Curtin K, Fonstad RK, Schiffman JD Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet A. 2014 Jun 16:
72. Turcotte L, Georgieff M,Ross J, Feusner, J, Tomlinson G, Malogolowkin M, Krailo M, Miller N, Fonstad R, Spector L Neonatal Medical Exposures and Characteristics of Low Birth Weight Hepatoblastoma Cases: A Report From the Children’s Oncology Group Pediatr Blood Cancer 2014 May
 
Books, Chapters, and Reviews
1. Siegel SE and Malogolowkin MH. Neoplasms of sex differentiation therapy. In: Martinez-Mora J, ed. Intersexual states: Disorders of sex differentiation. Barcelona, Spain: Ediciones Doyma SA; 1991:350-357
2. Ortega JA, Malogolowkin MH. Epithelial and neuroectodermal tumors of the GI, GU, and GYN tracts. In: Fernbach DK and Vietti TJ, ed. Clinical pediatric oncology. Fourth ed. Missouri: Mosby-Year Book; 1991:611-626
3. Ortega JA, Malogolowkin MH. Rhabdomyosarcomas of the gastro-intestinal tract. In: Maurer HM, Ruymann FB, and Pochedly C, ed. Rhabdoymosarcomas in children. Florida: CRC Press Inc.; 1991:333-346
4. Weiner JM, Malogolowkin MH. Sarcomas. In: Horowitz RS, ed. Idea Analysis in Cancer. Burbank, CA: Literature Analysis, Inc.; 1992
5. Weiner JM, Malogolowkin MH. Acute Myeloid Leukemia. In: Horowitz RS, ed. Idea Analysis in Cancer. Burbank, CA: Literature Analysis, Inc.; 1992
6. Weiner JM, Malogolowkin MH. Hodgkin's Disease. In: Horowitz RS, ed. Idea Analysis in Cancer. Burbank, CA: Literature Analysis, Inc.; 1992
7. Malogolowkin MH, Rowland J, Ortega JA. Rhabdomyosarcoma. In: Pochedly C, ed. Neoplastic Disease in Childhood. England, Harwood Academic Publishers; 1994:779-814
8. Malogolowkin MH. Hepatic tumors. In: Bast RC Jr, Kufe DW, Pollock RE, et al, ed. Cancer medicine. 5th ed. Hamilton, Ontario: Holland-Frei; 2000:2171-2173
9. Malogolowkin MH, Tishler DM, Tao ML. Retinoblastoma. In: Cancer treatment. 5th ed.;2001:1198-1204
10. Malogolowkin MH, Tao ML, Klipfel N, Bhuta SM, Atkinston JB. Wilm's tumor. In: Cancer treatment. 5th ed.;2001:1205-1214
11. Malogolowkin MH, Monforte HL, Kovanlikaya A, Siegel SE. Pediatric Germ Cell Tumors. In: ACS Atlas of Solid Tumors. 2003:265-286
12. Ortega JA, Malogolowkin MH, Monforte H. Tumores Hepaticos in Oncologia Pediatrica. In: Sierrasesumaga and Klussman, eds. Tratado de Oncologia Pediatrica. Spain, Universidad de Navarra; 2005:507-532
13. Malogolowkin MH, Quinn JJ, Steuber CP, Siegel SE. Clinical assessment and differential diagnosis of the child with suspected cancer. In: Pizzo and Poplack, eds. Principles and Practice of Pediatric Oncology. 5th Edition. Lippincott Williams & Wilkins; 2005:145-159
14. Wallace RJ Jr, Griffith DE. Antimycobacterial agents. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005:946
15. Malogolowkin MH, Spector L, Fong Y. Liver and intrahepatic bile duct cancers. In: Bleyer A, O’Leary M, Barr R, Ries LAG, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, MD, National Cancer Institute, NIH Pub. No. 06-5767; 2006:135-142
16. Casillas J, Ross J, Keohan ML, Bleyer A, Malogolowkin M. Soft tissue sarcomas. In: Bleyer A, O’Leary M, Barr R, Ries LAG, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, MD, National Cancer Institute, NIH Pub. No. 06-5767; 2006:81-96
17. Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M. Malignant bone tumors. In: Bleyer A, O’Leary M, Barr R, Ries LAG, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, MD, National Cancer Institute, NIH Pub. No. 06-5767; 2006:97-110
18. Malogolowkin MH, Zimmermann A, Plaschkes J. Liver Tumors. In: Bleyer A, Barr R, Albritton K, Philipps M. Springer, Verlag, eds. Cancer in Adolescents and Young Adults. Springer; 2007:311-330
19. Malogolowkin MH, Monforte H, Czauderna P, Perilongo G, Ortega JA. Childhood Hepatic Tumors. In: Carrol B, Finlay, Jones and Bartlett Eds. Cancer in Children: The Clinical Biology of Childhood Cancer. 2009:409-435
20. Kilburn LB, Malogolowkin MH, Quinn JJ, Siegel, SE, Steuber CP. Clinical Assessment and Differential Diagnosis of the Child With Suspected Cancer. In: Pizzo PA & Poplack DG, Eds. Principles and Practice of Pediatric Oncology. 6th Edition. Lippincott, Williams and Wilkins; 2010:123-137
21. Perilongo G, Morland B, Malogolowkin MH. Chemotherapy for Liver Tumour for Childhood Hepatoblastoma and Hepatocellular Carcinoma. In: Zimmerman A, Perilongo G, Malogolowkin MH, vonSchwinitz D, eds. Pediatric Liver Tumors. 1st Edition. Springer; 2010
22. Spreafico F, Malogolowkin MH. Treatment of Relapsed Wilms Tumor Patients. Oncopedia. 2012 May; http://www.cure4kids.org/private/oncochap/ocrev_269/Onco-Ch-56-Treat-Relapse-Wilms-Patient.pdf
23. Browning, M, Mortland, L, Malogolowkin, M. Chemotherapy in pediatric bone and soft-tissue sarcomas. in Current Ortho Practice. Editor Arkader A. Lippincott Williams & Wilkins. Accepted in print. 2013
 
Editorials, Letters to Editor, Other
1. Malogolowkin M, Miranda BL, Boechat MI Letter Reply “A case of Noonan’s syndrome with possible associated neuroblastoma”. Pediatr Radiol. 2000;30:433.
 
Abstracts
1. Malogolowkin MH, Ortega JA, Gonzales O, Siegel SE. Frequency of Malignancy at Recurrence in Teratomas with Immature Elements. International Society of Paediatric Oncology (SIOP) XIX Meeting Abstracts. Med Pediatr Oncol (currently Pediatr Blood Cancer). 1987;15(6):291-356
2. Malogolowkin MH, Siegel SE, Strandjord S, Sather H, Hammond GH. Melphalan (L-PAM) is active in untreated neuroblastoma. The American Society of Pediatric Hematology-Oncology, Chicago, 1989
3. Malogolowkin MH, Ortega JA. Effective Treatment for Advanced Ewing’s and Primitive Neuroectodermal Tumors (PNET). International Society of Paediatric Oncology (SIOP) XX Meeting Abstracts. Med Pediatr Oncol (currently Pediatr Blood Cancer). 1988;16(6):384-45312
4. Malogolowkin MH, Ortega JA. Treatment of Children with Bladder/Prostate Rhabdomyosarcoma (RMS) without Pelvic Exenteration. ASCO Annual Meeting Abstracts. J Clin Oncol. 1990;9(301):abstr 1167
5. Malogolowkin MH, Jacobs C, Horowitz RS, Weiner JM, Hammond GD. Computer Assisted Protocol Development in Cancer Clinical Trial Research. Proceedings Am Soc Information Science. 1990;27:181-19114
6. Malogolowkin MH, Stanley P, Daniels J, Ortega JA. Chemoembolization for Progressive Hepatoblastoma in Children. ASCO Annual Meeting Abstracts. J Clin Oncol. 1993;11(422):abstr 1450
7. Malogolowkin MH, Feusner J, Steele DA, Lavado MG, Ortega JA. Carboplatin (CBDCA)/Etoposide (VP-16) for the Treatment of Children with High-Risk or Recurrent Wilms’ Tumor. ASCO Annual Meeting Abstracts. J Clin Oncol. 1994;13(424):abstr 1453
8. Malogolowkin MH, Steele DA, Ortega JA, Rowland J, Scanlon KJ. Circumvention of Platinum Resistance by Azidothymidine (AZT) in Childhood Malignancies. Proceedings American Association for Cancer Research. AACR. 1994;35:470
9. Malogolowkin MH, Steele D, Deegan W, Ortega J, Murphree AL. Systemic Chemotherapy for Intraocular Retinoblastoma (IO-RB). ASCO Annual Meeting Abstracts. J Clin Oncol. 1995;14(449):abstr 1437
10. Villablanca JG, Madden T, Malogolowkin MH, Hager HK, Johansen MJ. Pharmacokinetics (PK) of Continuous Infusion High Dose Carboplatin in Children. ASCO Annual Meeting Abstracts. J Clin Oncol. 1995;14(174): abstr 380
11. Tannous R, Coccia P, Sposto R, Beckwith B, Giller R, Gyepes M, Holcomb G, Kim T, La Quaglia M, Malogolowkin MH, Stranjord S. Salvage Intensive/Sequential Chemotherapy (I/SCT) Plus Surgery (S) for Wilms Tumor (WT). A Children Cancer Group (CCG)-4921 Study Report. ASCO Annual Meeting Abstracts. J Clin Oncol. 1995;14(443):abstr 1415
12. Ortega JA, Rowland J, Monforte HL, Malogolowkin M, Triche T. Therapeutic Implications of Presence of differentiated Rhabodmyoblasts at the End of Therapy (TX) for Childhood Pelvic Rhabdomyosarcoma (RMS). ASCO Annual Meeting Abstracts. J Clin Oncol. 1996;15(461):abstr 1447
13. Roebuck DJ, Malogolowkin MH, Kovanlikaya A, Bottcher M, Gilsanz V, Ortega J. Defect in Bone Mineralization Following Ifosfamide (IF) Treatment for Childhood Sarcomas. International Society of Paediatric Oncology (SIOP) XXVII Meeting Abstracts. Med Pediatr Oncol. 1996 Oct;27(4):209-374
14. Ortega JA, Rowland J, Monforte HL, Malogolowkin MH, Triche T. Outcome of Children with Presence of Differentiated Rhabdomyoblasts at the End of Therapy (TX) for Rhabdomyosarcoma (RMS). International Society of Paediatric Oncology (SIOP) XXVII Meeting Abstracts. Med Pediatr Oncol. 1996 Oct;27(4):209-39024
15. Shaul D, Scheer B, Boody B, Malogolowkin, MH, Mason M, Mahour GH. Risk Factors for Early Infection of Central Venous Catheters in Pediatric patients. Annual Meeting of the Pacific Association of Pediatric Surgeons. J American Coll Surgeons. 1998;186(6):654-658
16. Ortega JA, Rios P, Malogolowkin, MH. Successful Treatment of Hepatoblastoma (HB) with Ann Intensified Platinum Regimen. ASCO Annual Meeting Abstracts. J Clin Oncol. 1998;17(545a):2091
17. Malogolowkin MH, Ortega JA, Carcich S, Steel DA, Tishler D, Franklin J, Nandy P, Periclou A, Cohen LJ, Avramis VI. Successful CSF Asparaginase (Asn) Depletion Following Administration of PEG-Asparaginase (PEG-ASNase) in Children with Acute Lymphoblastic Leukemia (ALL) with Isolated CNS Relapse. J Clin Oncol. ASCO Annual Meeting Abstracts. 1998;17(530a):2035
18. Rowland JM, Shu Q, Malogolowkin MH, Kuroda C, Peters J. Multidrug Resistance Gene Expression in Stage 4 Wilms’ Tumors: Correlation with Outcome. Annual Meeting of the Society for Pediatric Pathology. Lab Invest. 1998;78(5P)
19. Malogolowkin MH, Sposto R, Grovas L, Breneman J, Womer R, Ortega JA. Lack of Improvement in Survival of Children with Metastatic Rhabdomyosarcoma (RMS) Treated with Intensive Therapy Followed by Stem Cell Transplant (SCT) for Control of Minimal Residual Disease. ASCO Annual Meeting Abstracts. J Clin Oncol. 1999;18:abstr 2143
20. Green DM, Breslow NE, Beckwith B, Ritchey ML, Shamberger RC, Haase GM, D’Angio GJ, Donaldson MH, Grundy PE, Weetman RM, Coopes MH, Malogolowkin MH. Treatment with nephrectomy only for small, stage I/favorable histology Wilms tumor. A Report from the National Wilms Tumor Study Group. ASCO Annual Meeting Abstracts. J Clin Oncol. 2000;19:abstr 2289
21. Tannous R, Giller R, Holmes E, Kim T, La Quaglia M, Malogolowkin MH, Montebello J, Sposto R, Green D, Coccia P. Intensive Therapy for High Risk (HR) Relapsed Wilms Tumor (WT). A CCG-4921/POG-9445 Study Report. ASCO Annual Meeting Abstracts. J Clin Oncol. 2000;19:abstr 2315
22. Marina NM, London WB, Lauer SL, Giller R, Cushing B, Malogolowkin MH, Castleberry RC, Womer R. Prognostic Factors in Pediatric Patients with Extragonadal Germ Cell Tumors: A Pediatric Oncology Group and Children's Cancer Group Germ Cell Tumor Study. International Society of Paediatric Oncology (SIOP) XXXII Meeting Abstracts. Med Pediatr Oncol. 2000 Sep;35(3):365-7133
23. Malogolowkin MH, Bergman T, Seibel N, Dome J, Coccia P, Coppes M, Breslow N. Outcome and Prognostic Factors (PF) for Patients with Recurrent wilms Tumor (R-WT) – National Wilms Tumor Study –3 and 4 (NWTS 3,4). ASCO Annual Meeting Abstracts. J Clin Oncol. 2001; 20:abstr 3136
24. Van Tornout JM, Butturini A, Mascarenhas L, Malogolowkin MH, Siegel SE. Does race affect outcome in pediatric metastatic sarcoma? ASCO Annual Meeting Abstracts. J Clin Oncol. 2002;21:abstr 292736
25. Del Toro G, Malogolowkin MH, Giller R, London W, Davenport V, Bergeron S, Cairo MS. Alphafetoprotein (AFP) expression in pediatric solid tumors: a potential role for the use of targeted radioimmunotherapy with 90-Y-hAFP31 IgG1. 2nd International Congress on Monoclonal Antibodies in Cancer. IDrugs. 2002 Nov;5(11):1057-61
26. Jubran RF, Marachelian A, Malogolowkin MH. Outcome of patients with Langerhan’s cell histiocytosis with bone involvement. ASPHO Meeting Abstracts. Med Pediatr Oncol. 2002
27. Jubran RF, Marachelian A, Malogolowkin MH. Outcome of patients with Langerhan’s cell histiocytosis with bone involvement. XVIII Annual Meeting of the Histiocyte Society. Med Pediatr Oncol. 2003;40:171–186
28. Marina N, Malogolowkin MH, London WB, Frazier AL, Rescorla F, Billmire DF, Davis M, Perlman E, Giller R, Lauer S. Amifostine does not protect against the ototoxicity associated with high-dose cisplatin, etoposide and bleomycin (HD-PEB) in pediatric germ cell tumors (PGCT): A PGCT Intergroup Study. ASCO Annual Meeting Abstracts. J Clin Oncol. 2003;22:abstr 3208
29. Jubran RF, Marachelian A, Dorey F, Malogolowkin MH: Predictors of outcome in children with Langerhans cell histiocytosis. ASCO Annual Meeting Abstracts. J Clin Oncol. 2004;22(14S):abstr 8550
30. Malogolowkin MH, Katzenstein, HM, Krailo M, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Castleberry R: Intensive versus standard platinum therapy for the treatment of children with hepatoblastoma (HB): A report of the Intergroup Hepatoblastoma Study P9645. ASCO Annual Meeting Abstracts. J Clinical Oncology. 2004;22(14S):abstr 851643
31. Katzenstein HM, Chang K, Krailo M, Bowman L, Greffe B, Castleberry R, Malogolowkin MH. A randomized study of platinum based chemotherapy with or without amifostine for the treatment of children with hepatoblastoma (HB): A report of the Intergroup Hepatoblastoma Study P9645. ASCO Annual Meeting Abstracts. J Clin Oncol. 2004;22(14S):abstr 851844
32. Malogolowkin MH, Green DM, Cotton C, Breslow N, Perlman E, Miser J, Ritchey M, Thomas P, Kletzel M, Coccia PF. Treatment of Wilms Tumor Relapsing After Initial Treatment with Vincristine, Actinomycin D and Doxorubicin. A Report from the National Wilms Tumor Study (NWTS) Group. ASCO Annual Meeting Abstracts. J Clin Oncol. 2005;23(16S):abstr 850745
33. Green DM, Malogolowkin, MH, Cotton C, Math M, Breslow N, Perlman E, Miser J, Ritchey M, Thomas P, Grundy P, D’Angio G, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Chearer P, Coccia P, Kletzel M, Macklis R. Treatment of Wilms Tumor Relapsing After Initial Treatment with Vincristine and Actinomycin D. A Report from the National Wilms Tumor Study (NWTS) Group. ASCO Annual Meeting Abstracts. J Clin Oncol. 2005;23(16S):abstr 855146
34. Malogolowkin MH. Brain Metastases from Childhood Systemic Germ Cell Tumors. The Second International Symposium of CNS Germ Cell Tumors Abstracts. Neuro Oncol. 2005 Oct;7(4):513–533
35. Malogolowkin MH, Katzenstein HM, Krailo M, Feusner, J, Reynolds, M, Quinn JJ, Finegold M, Ortega J. “Outcome of Patients with Recurrent or Progressive Hepatoblastoma: A Report of the Intergroup Liver tumor Study INT-0098”. International Society of Paediatric Oncology (SIOP) XXXVII Annual Meeting Abstracts. Pediatr Blood Cancer. 2005;45(suppl 6):365–608
36. Madigan C, Malogolowkin MH, Mascarenhas L. Extra-Cranial Rhabdoid Tumor in Childhood: A Single Institution Experience. International Society of Paediatric Oncology (SIOP) XXXVII Annual Meeting Abstracts. Pediatr Blood Cancer. 2005;45(suppl 6):365–608
37. Malogolowkin MH, London WB, Giller R, Davis MM, Cullen J, Olson T. Site of Metastases Does Not Influence the Clinical Outcome of Children with Metastatic Germ Cell Tumors (GCT). A Report from the Children's Oncology Group. ASCO Annual Meeting Abstracts. J Clin Oncol. 2006;24(18S):abstr 9002
38. Malogolowkin, MH, Kazenstein H, Krailo M, Rowland J, Haas J, Meyers R, Finegold M. Complete surgical resection is curative children with pure fetal histology hepatoblastoma (PFH): A report of the Children's Oncology Group (COG). ASCO Annual Meeting Abstracts. J Clin Oncol. 2008;26:(May 20 suppl);abstr 10049
39. Marcio Malogolowkin, Wendy London, Lindsay Frazier, Thomas Olson. Brain Metastases in Children with High Risk Germ Cell Tumors (GCT): A report of the Children’s Oncology Group (COG). International Society of Paediatric Oncology (SIOP) XXXX Meeting Abstracts. 2008.
40. Malogolowkin MH, Krailo M, Frazier LA, Olson TA. Study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high-risk germ cell tumors. A Children’s Oncology Group report. ASCO Annual Meeting Abstracts. J Clin Oncol. 2009; 27:(15s, suppl):10035
41. Sanchez-Diaz PC, Chen TL, Meyers R, Malogolowkin MH, Hung JY, Tomlinson GE. Sorafenib, gamma-secretase inhibitor and bortezomib as potential therapeutic agents for hepatoblastoma. ASCO Annual Meeting Abstracts. J Clin Oncol. 2010;28:(15s, suppl):abstr 9550
42. Mascarenhas L, Armenian S, Harrington JL, Mahmoud H, Sposto R, Malogolowkin MH. Phase I trial of oxaliplatin and doxorubicin in children and adolescents with recurrent solid tumors. ASCO Annual Meeting Abstracts. J Clin Oncol. 2010;28(15 May Suppl):abstract 9543
43. Frazier L, Cullen, Krailo M, Rodriguez-Galindo C, Rescorla F, Ross J, Amatruda J, Egler R, Malogolowkin MH, Olson T, Davis M, Schlatter M, Billmire D. Stage I Ovarian Germ Cell Tumors: Outcome of a Watch and Wait Strategy. International Society of Paediatric Oncology (SIOP) XXXXII Annual Meeting Abstracts. Pediatr Blood Cancer. 2010;55:775–1014
44. Venkatramani R, Malogolowkin MH, Mascarenhas L. Pleuropulmonary Blastoma: Children’s Hospital Los Angeles Experience. International Society of Paediatric Oncology (SIOP) XXXXII Annual Meeting Abstracts. Pediatr Blood Cancer. 2010;55:775–1014
45. Venkatramani R, Wang L, Malvar J, Sposto R, Malogolowkin MH, Mascarenhas L. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. ASPHO Meeting Abstracts. Pediatr Blood Cancer. 2011;56:897–973
46. Mullen EA, James R, Steacy J, James I ,Green DM, Norkool P, Conrad V, Fernandez H, Malogolowkin MH, Dome JS. The impact of surveillance imaging on overall survival in patients with recurrent wilms tumor: A report from the children's oncology group. ASCO Annual Meeting Abstracts. J Clin Oncol. 2011;29(15 suppl):abstract 9536
47. Malogolowkin MH, Spreafico F, Dome JS, Breslow N, van Tinteren NH, Pritchard-Jones K, van den Heuvel, Bergeron MC, De Kraker J, Graf N. Incidence and outcomes of patients with late recurrence of Wilms tumor (WT): The international experience. ASCO Annual Meeting Abstracts. J Clin Oncol. 2011:29(15 suppl):abstract 9544
48. Lopez-Terrada D, Ranganathan S, Allagio R, De Davila MT, Tanaka Y, Leuschner I, Guettier C, Meyers R, Czauderna P, Malogolowkin M, Katzenstein H, Hiyama E, Brugieres L, Zimmermann A, Finegold MJ, Fabre M. Development and Validation of a Revisited International Classification of Hepatoblastoma (HBL), Hepatocellular Carcinoma (HCC) and Transitional Liver Tumours (TLT) in Children: A Proposal from the International Paediatric Liver Pathology Expert Committee from COG, GPOH, JPLT, and Siopel Groups, after Los Angeles Symposium and Paris Workshop in 2011. Pediatric Blood and Cancer (SIOP) 2012, London, United Kingdom; 59(6):abstr O061
49. Czauderna P, Meyers R, Hiyama E, Haeberle B, Rinaldi E, Maibach R, Krailo M, Aronson D, Hishiki T, Leuschner I, Lopez-Terrada D, von Schweinitz D, Schmidt I, Watanabe K, Yoshimura K, Covezzoli A, deRosa M, Malogolowkin M, Perilongo G. Childrens's Hepatoma International Collaboration (CHIC) Novel Inititative Creating a Global Retrospective Clinical Database and an International Risk Stratification System: Experience of the ENCCA (European Network For Cancer Research in Children and Adolescents) Consortium. Pediatric Blood & Cancer (SIOP) 2012, London, United Kingdom; 59(6): abstr O063
50. Venkatramani, R, Sapra, A, Stein, J, Genyk, Y, Mascarenhas, L, Sposto, R, Malogolowkin, M. Feasibility of early resection following neo-adjuvant chemotherapy for hepatoblastoma considered unresectable at diagnosis. ASPHO Meeting Abstracts. April 2013
51. Trobaugh-Lotrario, A, Chaiyachati, B, Meyers, R, Haberle, B, Tomlinson, G, Katzenstein, H, Malogolowkin, M, Von Schweinitz, D, Krailo, M, Feusner, JH. Outcome in congenital hepatoblastoma is better than previously reported. ASCO annual meeting abstract, 2013
52. Venkatramani, R, Malogolowkin, M, Davidson, T, May, W, Sposto, R, Mascarenhas, L. A phase I study of Vincristine, Irniotecan, Temozolomide and Bevacizumab (VITB) in pediatric patients with relapsed solid tumors. ASPHO Abstract Annual Meeting, 4/2013